TY - JOUR
T1 - Cyclic peptide structure prediction and design using AlphaFold2
AU - Rettie, Stephen A.
AU - Campbell, Katelyn V.
AU - Bera, Asim K.
AU - Kang, Alex
AU - Kozlov, Simon
AU - Bueso, Yensi Flores
AU - De La Cruz, Joshmyn
AU - Ahlrichs, Maggie
AU - Cheng, Suna
AU - Gerben, Stacey R.
AU - Lamb, Mila
AU - Murray, Analisa
AU - Adebomi, Victor
AU - Zhou, Guangfeng
AU - DiMaio, Frank
AU - Ovchinnikov, Sergey
AU - Bhardwaj, Gaurav
N1 - Publisher Copyright:
© The Author(s) 2025.
PY - 2025/12
Y1 - 2025/12
N2 - Small cyclic peptides have gained significant traction as a therapeutic modality; however, the development of deep learning methods for accurately designing such peptides has been slow, mostly due to the lack of sufficiently large training sets. Here, we introduce AfCycDesign, a deep learning approach for accurate structure prediction, sequence redesign, and de novo hallucination of cyclic peptides. Using AfCycDesign, we identified over 10,000 structurally-diverse designs predicted to fold into the designed structures with high confidence. X-ray crystal structures for eight tested de novo designed sequences match very closely with the design models (RMSD < 1.0 Å), highlighting the atomic level accuracy in our approach. Further, we used the set of hallucinated peptides as starting scaffolds to design binders with nanomolar IC50 against MDM2 and Keap1. The computational methods and scaffolds developed here provide the basis for the custom design of peptides for diverse protein targets and therapeutic applications.
AB - Small cyclic peptides have gained significant traction as a therapeutic modality; however, the development of deep learning methods for accurately designing such peptides has been slow, mostly due to the lack of sufficiently large training sets. Here, we introduce AfCycDesign, a deep learning approach for accurate structure prediction, sequence redesign, and de novo hallucination of cyclic peptides. Using AfCycDesign, we identified over 10,000 structurally-diverse designs predicted to fold into the designed structures with high confidence. X-ray crystal structures for eight tested de novo designed sequences match very closely with the design models (RMSD < 1.0 Å), highlighting the atomic level accuracy in our approach. Further, we used the set of hallucinated peptides as starting scaffolds to design binders with nanomolar IC50 against MDM2 and Keap1. The computational methods and scaffolds developed here provide the basis for the custom design of peptides for diverse protein targets and therapeutic applications.
UR - https://www.scopus.com/pages/publications/105005605249
U2 - 10.1038/s41467-025-59940-7
DO - 10.1038/s41467-025-59940-7
M3 - Article
C2 - 40399308
AN - SCOPUS:105005605249
SN - 2041-1723
VL - 16
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 4730
ER -